BioMarker Strategies
BioMarker Strategies Wins NCI Grant to Develop Head and Neck Cancer CDx
The company is developing a companion diagnostic to identify head and neck cancer patients most likely to benefit from Erbitux.
The company is developing a companion diagnostic to identify head and neck cancer patients most likely to benefit from Erbitux.